Illumina sequencing platforms
GPTKB entity
Statements (62)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:DJ
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Illumina_Nextera
gptkb:Illumina_Tru_Seq_Custom_Amplicon_Kit gptkb:Illumina_Tru_Seq_Custom_Amplicon_Panel gptkb:Illumina_Tru_Seq_RNA_Library_Prep_Kit_v2 gptkb:Illumina_Tru_Seq_Targeted_RNA_Expression_Panel gptkb:Illumina_Software |
gptkbp:analysis |
requires bioinformatics tools
|
gptkbp:application |
whole genome sequencing
RNA sequencing exome sequencing targeted resequencing |
gptkbp:collaborations |
pharmaceutical companies
various academic institutions |
gptkbp:developed_by |
gptkb:Illumina,_Inc.
|
gptkbp:first_released |
gptkb:2006
|
gptkbp:has_programs |
gptkb:Base_Space_Sequence_Hub
Illumina Cloud Illumina DRAGEN |
https://www.w3.org/2000/01/rdf-schema#label |
Illumina sequencing platforms
|
gptkbp:impact |
contributed to cancer research
enhanced understanding of genetic diseases facilitated large-scale genomic studies enabled personalized medicine revolutionized genomics research |
gptkbp:input_output |
gptkb:FASTQ
gptkb:BAM VCF up to several terabases per run |
gptkbp:is_used_for |
DNA sequencing
|
gptkbp:length |
up to 300 base pairs
|
gptkbp:library |
requires specific protocols
|
gptkbp:market |
dominant in the sequencing market
|
gptkbp:performance |
high
|
gptkbp:platform |
gptkb:Mi_Seq
gptkb:Nova_Seq gptkb:Next_Seq Hi Seq |
gptkbp:population_trend |
improved accuracy
increased automation lower costs expanded applications integration with AI |
gptkbp:price |
varies by platform and application
|
gptkbp:recorded_by |
gptkb:DJ
gptkb:CEO c DNA amplified DNA |
gptkbp:regulatory_compliance |
FDA approved for certain applications
|
gptkbp:seed_dispersal |
gptkb:military_unit
customizable decreasing over time sequencing by synthesis |
gptkbp:supports |
extensive customer support
|
gptkbp:technology |
next-generation sequencing
|
gptkbp:training |
for effective use
|
gptkbp:used_in |
genomics
|
gptkbp:user_base |
gptkb:physicist
biotech companies clinicians pharmaceutical researchers |